Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionStraight Path Wealth Management
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Straight Path Wealth Management ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On April 22, 2026 - Straight Path Wealth Management filed a 13F-HR form disclosing ownership of 0 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 50,000 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Straight Path Wealth Management has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -50,000 -100.00 0 -100.00
2026-02-11 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,000 0 0.00 1,560 54.46 0.4208
2025-11-03 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,000 0 0.00 1,010 20.53 0.2724
2025-07-29 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,000 0 0.00 838 9.11 0.2845
2025-04-28 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,000 -16,000 -24.24 768 -47.18 0.3109
2025-02-06 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 1,455 22.29 0.5754
2024-11-06 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 1,189 10.91 0.5123
2024-08-15 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 1,072 15.15 0.5509
2024-04-30 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 931 35.12 0.5228
2024-01-23 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 689 2.38 0.4042
2023-10-31 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 673 35.69 0.4564
2023-07-25 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 -25,000 -27.47 497 -38.39 0.3411
2023-04-26 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 91,000 0 0.00 805 -2.90 0.6406
2023-01-20 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 91,000 19,600 27.45 830 43.92 0.7953
2022-10-21 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 71,400 5,400 8.18 576 16.13 0.5173
2022-07-19 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 0 0.00 496 -20.00 0.4859
2022-04-29 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 66,000 10,000 17.86 620 38.08 0.5251
2022-01-26 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 56,000 56,000 449 0.3913
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-03 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 30,000 606 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.